Sponsor or institution

Clinical trials and research at CHU de Quebec-Universite Laval

• 23Clinical trials
• 1Country

Newest trials

All recruiting trials (23)

• Therapeutic patient education for adults with obesity and metabolic disorders

  Aimed at adults with obesity, this study tests whether a co-developed therapeutic patient education program is acceptable and feasible to help with daily self-management.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT07668661

• Shorter Salvage Radiotherapy after Prostate Surgery for Recurrent Prostate Cancer

  This study tests whether a shorter, 4-week salvage radiotherapy schedule is as safe and effective as the standard 5-week schedule for men with prostate cancer that has come back after surgery.

  Recruiting CHU de Quebec-Universite Laval · Gatineau, Quebec and 3 other locations · NCT07483658

• Dutasteride to prevent recurrence of low-grade non-muscle invasive bladder cancer

  This will see if taking the oral medicine dutasteride can lower the chance that low-grade non-muscle invasive bladder cancer comes back in adults.

  Recruiting Phase 2 CHU de Quebec-Universite Laval · Québec, Quebec · NCT07420517

• Four-timepoint PET scans with three tracers to map differences between prostate cancer metastases

  This will test whether repeating PET scans with three different tracers can map active, treatment‑resistant versus treatment‑sensitive metastases in men with metastatic castration‑resistant prostate cancer who have at least three metastases.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT07302763

• Gene-modified autologous skin graft (GMEB-SASS) for RDEB

  This trial will try a gene-modified skin graft grown from a patient's own cells to help wounds heal in people with recessive dystrophic epidermolysis bullosa (RDEB).

  Recruiting Phase 1/2 CHU de Quebec-Universite Laval · Toronto, Ontario · NCT07193134

• Target IgG levels for people with multiple myeloma on BCMA-directed T-cell engager therapy

  This will test whether keeping IgG levels at 4–6 g/L works as well as 8–10 g/L to prevent severe infections in adults with relapsed or refractory multiple myeloma who are receiving BCMA-directed T-cell engager therapy.

  Recruiting at 2 sites Phase 4 CHU de Quebec-Universite Laval · Lévis, Quebec and 1 other locations · NCT07094048

• Self‑questionnaire to spot rare genetic bone conditions in adults with osteoporosis

  This project tests whether a self‑administered questionnaire can help identify rare genetic bone diseases in adults with osteoporosis.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT07067827

• Personalized versus fixed‑dose Lutetium‑177 PSMA therapy for metastatic castration‑resistant prostate cancer

  This study will test whether personalizing Lutetium‑177 PSMA dosing using kidney dosimetry lets men with metastatic castration‑resistant prostate cancer safely receive higher treatment activity than the standard fixed dosing.

  Recruiting Phase 1 CHU de Quebec-Universite Laval · Québec, Quebec · NCT06943495

• Adapted group cognitive-behavioral therapy for fear of cancer returning in women with BRCA1 or BRCA2 mutations

  This project tests an adapted group cognitive-behavioral therapy to reduce fear of cancer returning in women who carry BRCA1 or BRCA2 mutations and have finished primary treatment.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06817694

• Impact of Sleeve Gastrectomy on Bone and Muscle Health in Men and Women

  This study is trying to see how sleeve gastrectomy affects bone and muscle health in men and women over three years.

  Recruiting CHU de Quebec-Universite Laval · Québec · NCT06547515

• Measuring eye pressure after vitrectomy using different devices

  This study is testing two new portable devices for measuring eye pressure after eye surgery to see if they work as well as the traditional method.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06522867

• Using capillaroscopy to improve diagnosis in patients with undifferentiated connective tissue disease

  This study is testing if using a special microscope to look at tiny blood vessels can help doctors better diagnose and manage patients with undifferentiated connective tissue disease.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06399822

• Pain management after mastectomy with reconstruction

  This study tests if a special pain relief technique can help women feel less pain after having a mastectomy with reconstruction and reduce the chances of long-term pain problems.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06276257

• Comparing two treatments for localized prostate cancer

  This study is testing whether a new type of radiation therapy is safer and has fewer side effects than a different kind for men with early-stage prostate cancer.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT06052683

• Prophylactic Tamsulosin to Prevent Postoperative Urinary Retention After Rectal Resection

  This phase III trial tests whether taking a 0.4 mg dose of tamsulosin around the time of rectal resection can reduce postoperative urinary retention in men.

  Recruiting Phase 3 CHU de Quebec-Universite Laval · Québec, Quebec · NCT05941806

• Comparing surgical methods for retinal detachment repair

  This study is testing two different surgical methods for fixing retinal detachment to see which one works better for patients and how different types of gas used during surgery affect their recovery.

  Recruiting CHU de Quebec-Universite Laval · Québec, Quebec · NCT05863312

• Comparing two types of radiation therapy for prostate cancer treatment

  This study is testing whether a new type of radiation therapy for prostate cancer works better and is safer than a different method, while also looking at how well the treatment is tolerated by patients.

  Recruiting CHU de Quebec-Universite Laval · Québec · NCT05786742

• Using bicalutamide with BCG treatment for bladder cancer

  This study is testing if adding a drug called bicalutamide to the standard BCG treatment can help people with non-muscle invasive bladder cancer have fewer recurrences of their cancer.

  Recruiting at 7 sites Phase 2 CHU de Quebec-Universite Laval · London, Ontario and 6 other locations · NCT05327647

• Improving medication management for seniors with major neurocognitive disorders

  This study is testing a new way for doctors, nurses, and pharmacists to work together to help seniors with major neurocognitive disorders manage their medications better and stay healthy.

  Recruiting at 2 sites CHU de Quebec-Universite Laval · Montreal, Quebec and 1 other locations · NCT04889794

• Impact of Bariatric Surgery on Bone Health in Type 2 Diabetes Patients

  This study is testing how sleeve gastrectomy surgery affects bone health in people with type 2 diabetes compared to those who are overweight but don’t have diabetes.

  Recruiting CHU de Quebec-Universite Laval · Montreal, Quebec and 2 other locations · NCT03455868

• Biobank for studying pregnancy complications like preeclampsia and preterm birth

  This study collects samples and information from pregnant women to see if it can help identify the causes of complications like preeclampsia and preterm birth.

  Recruiting CHU de Quebec-Universite Laval · Québec · NCT02744365

• Self Assembled Skin Substitute for treating severe burn wounds

  This study tests if a new skin substitute can help heal severe burn wounds for people who don’t have enough healthy skin to use for traditional grafts.

  Recruiting at 8 sites Phase 1/2 CHU de Quebec-Universite Laval · Calgary, Alberta and 7 other locations · NCT02350205

• Using cultured corneal cells to treat limbal stem cell deficiency

  This study is testing if transplanting specially grown corneal cells can help people with limbal stem cell deficiency improve their eye health and vision.

  Recruiting at 4 sites CHU de Quebec-Universite Laval · Toronto, Ontario and 3 other locations · NCT01756365

Quick answers

How many clinical trials run by CHU de Quebec-Universite Laval are recruiting right now?

23, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Canada. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1/2: 2, Phase 4: 1, Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →